Horizon Capital is a private equity fund manager that originates and manages investments in mid-cap companies with solid growth and profit potential in Ukraine and the region.
Company overview
We support visionary entrepreneurs, transforming the business landscape in Ukraine and the region
Company overview
-
STADA to Become a Major Pharma Player in Ukraine by Acquiring Biopharma’s Pharmaceutical Prescription and Consumer Health Business
-
Horizon Capital’s EEGF II fully exits Purcari Wineries, generating 3.3x cash-on-cash
-
Biopharma has launched a state-of-the-art $75 million plasma fractionation plant in Ukraine
Our strategy is to identify high quality management teams and capitalize on specific market opportunities in the fastest growing segments of these emerging markets.
Investment funds